...
首页> 外文期刊>Frontiers in Pediatrics >Risk Factors for Necrotizing Enterocolitis in Infants With Patent Arterial Duct. A Retrospective Matched Paired Analysis
【24h】

Risk Factors for Necrotizing Enterocolitis in Infants With Patent Arterial Duct. A Retrospective Matched Paired Analysis

机译:专利动脉管道中婴儿坏死性肠核性危险因素。回顾性匹配配对分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The development of necrotizing enterocolitis (NEC) in neonates with patent ductus arteriosus (PDA) is not well understood. Our aim was to find risk factors for NEC in children with a significant PDA and to assess differences in mortality and duration of hospital stay between patients with PDA and those with PDA and NEC. We performed a retrospective single center case control study including infants with PDA scheduled for treatment. We compared multiple patient data between patients with PDA and those with PDA and NEC from 2004 to 2018. 2018 using 1:2 and 1:1 matching. We used 1:2 matching with 26 NEC patients (cases) and 52 PDA patients without NEC (controls) and 1:1 matching with 5 NEC patients and 5 PDA patients without NEC. NEC patients had lower Apgar score (1’), more congenital malformations, more suspected sepsis, less hypotension, higher minimum platelet count and higher CRP-values during the week before NEC (P0.05, respectively). The mortality was higher in NEC cases [29% (9/31)] compared to the control patients [2% (1/57), P0.001]. Lower Apgar score (1â€?) was correlated with an increased risk of NEC stage III. Hypotension was inversely correlated with the odds of NEC (OR 0.3). NEC increased mortality in infants with PDA. Hypotension did not increase the risk of NEC in infants with PDA. Routine clinical parameters were not able to predict NEC in infants who suffer from PDA.
机译:Neoxates中的坏死性肠腐殖炎(PDA)的新生儿肠炎(PDA)的发展尚不清楚。我们的目的是寻找具有重要PDA的儿童NEC的风险因素,并评估PDA患者和PDA和NEC患者之间死亡率和住院时间持续时间的差异。我们进行了回顾性单中心案例控制研究,包​​括预定PDA的婴儿进行治疗。我们比较了PDA患者的多重患者数据和2004年至2018年的PDA和NEC。2018年使用1:2和1:1匹配。我们使用了1:2与26名NEC患者(病例)和52名没有NEC(对照)和1:1与5个NEC患者的患者和52名没有NEC患者的匹配。 NEC患者具有较低的APGAR评分(1'),更先天性畸形,更具疑似脓毒症,低血管畸形,较低的低血压计数和NEC前一周内的最低CRP值(分别为P <0.05)。与对照患者相比,NEC病例中的死亡率较高[29%(9/31)] [2%(1/57),P <0.001]。降低APGAR评分(1)与NEC阶段III的风险增加相关。低血压与NEC(或0.3)的几率与逆转。 NEC增加了PDA婴儿的死亡率。低血压没有增加PDA婴儿NEC的风险。常规临床参数无法预测患有PDA的婴儿的NEC。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号